Nilaya Varma, Co-founder and Group CEO, Primus Partners, highlights that India’s aesthetic injectable and non-invasive treatment markets, valued at $232.9 million and $1.9 billion respectively in 2023, are set for rapid growth. Driven by rising awareness, technological innovation, and medical tourism, these sectors are expected to grow at compound annual growth rates of 15% and 19.2% through 2030.